Overview
Multidisciplinary Strategies to Prevent Hospitalization in Patients with Worsening Heart Failure (HF)
Click the"View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity
Despite guideline-directed medical therapy, many patients with heart failure (HF) with reduced ejection fraction continue to experience worsening HF and hospitalizations. As such, it is incumbent upon clinicians to improve familiarity and competence with available therapies and clinical trial data that may guide patient selection to individualize and optimize therapy for patients with HF. In this interactive practice guide, clinicians can access real-world strategies and expert insights to improve the care of their patients with worsening HF.
This activity is intended for cardiologists, interventional cardiologists, pharmacists, nurses, and others on the multidisciplinary team involved in the care of patients with worsening heart failure.
HF is a complex disease associated with adverse outcomes and poor quality of life for patients. It is also a significant driver of hospitalizations and readmissions. Delays in diagnosis, misdiagnosis, and undertreatment are common as patients often see a multitude of healthcare providers. Yet, early recognition and treatment are critical to reducing morbidity and mortality associated with HF, particularly those with worsening HF and after recent HF hospitalization. There have been significant advances in treatment with new disease-modifying agents introduced. Despite the accumulating evidence and calls for guideline-directed medical therapy, this approach is underutilized and clinicians struggle to initiate and optimize therapy in clinical practice. In addition, many clinicians remain unaware of novel strategies for patients with worsening HF or after recent HF hospitalization. This interactive practice guide can help learners become better prepared to assess and manage patients with worsening HF.
Upon completion of this activity, learners will be able to:
• Describe unmet needs and clinical practice gaps for complex patients with worsening HF and implications for treatment burden and quality of life
• Identify prognostic factors to classify the severity of patients with worsening HF
• Evaluate the effectiveness of novel therapies for patients who continue to experience symptoms and hospitalization due to worsening HF
• Create individualized HF treatment plans for optimal management of patients with worsening HF
• Describe unmet needs and clinical practice gaps for complex patients with worsening HF and implications for treatment burden and quality of life
• Identify prognostic factors to classify the severity of patients with worsening HF
• Evaluate the effectiveness of novel therapies for patients who continue to experience symptoms and hospitalization due to worsening HF
• Create individualized HF treatment plans for optimal management of patients with worsening HF
This educational activity is presented in collaboration with Rush University Medical Center and Academy for Continued Healthcare Learning (ACHL).
Supported by an educational grant from Merck & Co., Inc..
1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
7. Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
7. Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
• Defining Worsening Heart Failure
• The Clinical Course of Worsening HF
• Recognizing Worsening HF
• Prevention of Worsening HF: GDMT
• Pharmacologic Therapy for Worsening HF
• Transitions of Care and Team-Based Approaches
• The Clinical Course of Worsening HF
• Recognizing Worsening HF
• Prevention of Worsening HF: GDMT
• Pharmacologic Therapy for Worsening HF
• Transitions of Care and Team-Based Approaches
Javed Butler, MD, MPH, MBA
Professor of Medicine
University of Mississippi
Jackson, MS
Professor of Medicine
University of Mississippi
Jackson, MS
Monique Colbert, MS, ACNP-BC
University Cardiologists
Rush University Medical Center
Chicago, IL
B. Andrew Mardis, PharmD, BCCP, BCTXP, BCPS
Clinical Pharmacy Specialist – Advanced Heart Failure
Prisma Health
Affiliate Clinical Assistant Professor
University of South Carolina College of Pharmacy
Columbia, SC
It is the policy of Rush University Medical Center and the Office of Interprofessional Continuing Education to ensure that its CE activities are independent, free of commercial bias and beyond the control of persons or organizations with an economic interest in influencing the content of CE. All individuals in control of educational content must disclose all financial relationships with ineligible companies in the past 24 months. An ineligible company is an entity whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. All conflicts of interest, including potential ones, for individuals in control of educational content are mitigated prior to the planning, implementation, or evaluation of the continuing education activity.
The IPCE identifies the presence or absence of relevant financial relationships for all individuals in control of content including but not limited to planning committee members, course directors, invited presenters/authors, and staff through a standardized disclosure form. If a financial relationship is identified for the person in control of content, conflict mitigation strategies will be used to mitigate the financial relationship before they assume their role.
The IPCE identifies the presence or absence of relevant financial relationships for all individuals in control of content including but not limited to planning committee members, course directors, invited presenters/authors, and staff through a standardized disclosure form. If a financial relationship is identified for the person in control of content, conflict mitigation strategies will be used to mitigate the financial relationship before they assume their role.
The following financial relationships have been provided:
Javed Butler, MD, MPH, MBA
Consultant: 3ivelabs, Abbott, Amgen, American Regent, Applied Therapeutics, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Cardiac Dimension, Cardior, CVRx, Cytokinetics, Edwards, Element, Faraday, G3 Pharmaceutical, Imbria, Impulse Dynamics, Innolife, Inventiva, Ionis, Janssen, LivaNova, Lexicon, Medtronic, Merck, Novartis, Novo Nordisk, Otsuka, Occlutech, PharmaCosmos, Roche, Sanofi, Secretome, Sequana, Tricog, Vifor
Speakers Bureau: Novartis, Boehringer Ingelheim-Lilly, Astra Zeneca, Impulse Dynamics
Monique Colbert, MS, ACNP- BC
No financial relationships to disclose
B. Andrew Mardis, PharmD, BCCP, BCTXP, BCPS
Consultant: Wolters Kluwer
Speakers Bureau: AstraZeneca, Boehringer-Ingelheim
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None
Unapproved Uses of Drugs/Devices: In accordance with requirements of the FDA, the audience is advised that information presented in this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA approved package insert for each drug/device for full prescribing/utilization information.
Rush University Medical Center and the Office of Interprofessional Continuing Education staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of any ineligible company. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor(s).
This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This activity will take approximately 60 minutes to complete. To receive credit, learners are required to complete the pretest, view the online activity, and complete the posttest and evaluation. To receive credit, 75% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
This activity is being presented without bias and with commercial support.
Rush University Medical Center designates this Internet Enduring Material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Rush University Medical Center designates this Internet Enduring Material for a maximum of 1.0 nursing contact hour(s).
Rush University Medical Center designates this knowledge-based Internet Enduring Material for a maximum of 1.0 contact hour(s) for pharmacists. ACPE Universal Activity Number: JA0000275-0000-23-087-H01-P
MIPS Improvement Activity
Completion of this activity, including the pretest, posttest, and follow-up assessments, qualifies as a medium weight MIPS improvement activity under MACRA and can be claimed as completion of IA_PSPA 28 of an Accredited Safety or Quality Improvement Program in the Quality Payment Program. Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website. You will receive additional information after completing the activity and receiving your certificate via email.
